iShares Nasdaq Biotechnology (IBB) Sees Green-to-Red Reversal
- Wall Street dips on Trump protectionism, Qualcomm drag
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- After-Hours Stock Movers 1/23: (REXX) (MRCY) (SYNC) Higher; (FSM) (OCUL) (CASC) Lower (more...)
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
iShares Nasdaq Biotechnology (NASDAQ: IBB) is coming in sharply from earlier highs and have turned red. IBB is down 0.3% currently.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gundlach sees Trump views weakening dollar, boosting TIPS demand
- Rite Aid (NYSE: RAD) puts active into close
- Options with increasing volume: FNSR P GPL QCOM RAD
Create E-mail Alert Related CategoriesETFs, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!